Učitavanje...

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML

We conducted a phase 1 study using midostaurin (25 mg or 50 mg orally twice daily), all-trans retinoic acid (ATRA) and CLAG chemotherapy to target multiple pathways in relapsed/refractory AML. 10 patients received the combination and no dose limiting toxicities were observed. Two patients (22%) achi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Hematol
Glavni autori: Ramsingh, Giridharan, Westervelt, Peter, McBride, Ali, Stockerl-Goldstein, Keith, Vij, Ravi, Uy, Geoffrey, Cashen, Amanda, DiPersio, John F., Abboud, Camille N.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4406413/
https://ncbi.nlm.nih.gov/pubmed/24488798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-014-1503-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!